A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael P. Brown |
| Publication date | March 31, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |